Adverse Drug Reaction News Bulletins
ADR News Bulletin 2012 December (Volume 14 Number 3)
Audiences
Healthcare professional
Industry member
Product type
Others
1 December 2012
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Vertical transmission of hepatitis B despite immunoprophylaxis
Appropriate route for the administration of bortezomib (Velcade®)
Safety updates on the risk of QT prolongation and cardiac arrhythmia, including Torsades de Pointes with intravenous ondansetron
New look for Health Products Regulation Group (HPRG) home page
List of Dear Healthcare Professional Letters (DHCPL) issued by HSA, pharmaceutical and medical device companies
Safety update on proton pump inhibitors
HSA hosts pharmacovigilance training course for Asia-Pacific countries
Changes to the safety-related product label amendments webpage
Recent product safety-related articles published on HSA website
Chinese Proprietary Medicines containing berberine will be allowed for sale in Singapore from 1 January 2013
Click on the link below to download the issue in pdf: